← Back to Search

Tailored message for Colorectal Cancer

N/A

Waitlist Available

Led By Michael L Kochman, MD

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 120 days

Awards & highlights

Study Summary

This trial will test whether sending patients tailored messages before their colonoscopy will increase the chance that they will follow their provider's recommendations.

Eligible Conditions

Colorectal Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 120 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~120 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 120 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Colonoscopy completion rate

Secondary outcome measures

Colonoscopy scheduling rate

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Tailored MessageExperimental Treatment1 Intervention

Participants in this arm will receive a telephone call from a study team member, and if no answer, up to two additional attempts will be made. During the telephone call, the participant will answer a series of 7 questions then receive a "tailored" message encouraging colonoscopy scheduling, which will be determined by their responses to the preceding questions.

Group II: Generic MessageExperimental Treatment1 Intervention

Participants in this arm will receive a telephone call from a study team member, and if no answer, up to two additional attempts will be made. During the telephone call, the study team member will ask the participant a series of 7 questions then receive a "generic" message encouraging colonoscopy scheduling.

Group III: Usual CareActive Control1 Intervention

Participants in this arm will Usual scheduling process without any intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Generic message

2017

N/A

~600

Tailored message

2021

N/A

~1550

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,000 Previous Clinical Trials

42,879,488 Total Patients Enrolled

Michael L Kochman, MDPrincipal InvestigatorUniversity of Pennsylvania

2 Previous Clinical Trials

705 Total Patients Enrolled

Media Library

Tailored message Clinical Trial Eligibility Overview. Trial Name: NCT03310892 — N/A

Colorectal Cancer Research Study Groups: Usual Care, Generic Message, Tailored Message

Colorectal Cancer Clinical Trial 2023: Tailored message Highlights & Side Effects. Trial Name: NCT03310892 — N/A

Tailored message 2023 Treatment Timeline for Medical Study. Trial Name: NCT03310892 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are geriatric individuals being admitted to this clinical experiment?

"Patients must fall between the ages of 50 and 75 to be accepted into this clinical trial. 38 studies are available for minors, while 1050 trials can be found for those over 65 years old."

Answered by AI

What are the eligibility requirements for participation in this trial?

"This clinical trial is actively recruiting 600 individuals between the ages of 50 and 75 who have colorectal cancer. Participants must be University of Pennsylvania Health System (UPHS) patients with a current order for screening or surveillance colonoscopy that do not already have an appointment. Furthermore, they should not have had any evidence of: fecal immunochemical testing in the past year, flexible sigmoidoscopy or CT colonography within the last 5 years, stool DNA test or Cologuard in the 3 preceding years."

Answered by AI

Are there still vacancies in this exploratory research program?

"Clinicaltrials.gov reveals that the recruitment phase for this trial is complete, with its initial post dated October 9th 2017 and latest update on September 26 2022. Nevertheless, there are a large number of other trials actively recruiting patients at present (1,064)."

Answered by AI

Recent research and studies

JAMA Network OpenJournal

Effect of Patient-directed Messaging on Colorectal Cancer Screening

Oyalowo, Akinbowale, Kimberly A. Forde, Alicia Lamanna, and Michael L. Kochman. 2022. “Effect of Patient-directed Messaging on Colorectal Cancer Screening”. JAMA Network Open. American Medical Association (AMA). doi:10.1001/jamanetworkopen.2022.4529.

clinicaltrials.govStudy

Tailored Messaging for CRC Screening

2017. "Tailored Messaging for CRC Screening". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03310892.